v3.26.1
Segment (Details)
 6 Months Ended
Jun. 30, 2026
Segments
Schedule of Total Assets [Line Items]  
Segment Reporting, Expense Information Used by CODM, Description The CODM evaluates the performance of the genetic diagnostic testing segment based on the Company’s net loss as reported on the statements of comprehensive loss as consolidated net loss and operating expense summary (Note 11). The Company’s segment assets are reported on the balance sheet as its total consolidated assets
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Chief Executive Officer
Number of Reportable Segments 2